MedAssets (MDAS +19%) pops after its Q3 shreds Street EPS estimates. Net revenue rose 50% Y/Y,...

|By:, SA News Editor

MedAssets (MDAS +19%) pops after its Q3 shreds Street EPS estimates. Net revenue rose 50% Y/Y, primarily due to a lower tax rate and write-downs related to its 2010 acquisition of Broadlane. Oppenheimer and Morgan Stanley both issue positive comments after the results, reiterating their Outperform and Overwieght ratings on the shares (I, II).